Key result
Biodegradable smart vascular grafts enable real-time monitoring of vascular complications in preclinical models.
Why the study?
Cardiovascular diseases and post-revascularization complications such as thrombosis, stenosis, and restricted blood flow are dynamic conditions that are difficult to capture through single time-point imaging examinations. Biodegradable smart vascular grafts offer a potential solution by supporting vascular reconstruction while continuously acquiring diagnostic signals near the lesion.
Biodegradable smart vascular grafts offer a promising preclinical approach for continuous real-time monitoring and adjunctive diagnosis of post-revascularization complications like thrombosis and stenosis, though clinical validation is still needed.
Answers are grounded in this paper and cite their sources.
Smart grafts enable integrated monitoring in animal models; hypothesis-generating, should not yet change clinical practice.
Cardiovascular diseases and post-revascularization complications, including thrombosis, stenosis, and restricted blood flow, are dynamic conditions that are difficult to capture through single time-point imaging examinations. Biodegradable smart vascular grafts use a biodegradable graft as the structural substrate and integrate pressure, strain, flow, impedance, or biochemical sensing units into the vascular wall. Thus, they can simultaneously support vascular reconstruction and continuously acquire signals near the lesion. Focusing on disease diagnosis, this review discusses the working principles, diagnosis-oriented material selection, and fabrication of these grafts, with particular emphasis on real-time monitoring, risk warning, and the auxiliary diagnostic value of hemodynamic abnormalities, thrombosis, stenosis, and occlusion. Current evidence is derived mainly from in vitro experiments, animal models, and prototype-device validation. At present, these devices should be regarded as tools for real-time monitoring and adjunctive diagnosis rather than replacements for clinical confirmation by ultrasonography, angiography, or other standard methods.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted a review in Cardiovascular diseases and post-revascularization complications (thrombosis, stenosis, occlusion, and restricted blood flow). Biodegradable smart vascular grafts integrated with pressure, strain, flow, impedance, or biochemical sensing units vs. Standard diagnostic methods such as ultrasonography and angiography was evaluated on Real-time monitoring, risk warning, and auxiliary diagnosis of hemodynamic abnormalities, thrombosis, stenosis, and occlusion. Biodegradable smart vascular grafts enable real-time monitoring and adjunctive diagnosis of vascular complications in preclinical models.